News

• 9/6/2022

Our CEO, Uroš Kuzmanović, was recently spotlighted on the BU OTD newsletter for his tremendous work in getting the company to its current stage. Congratulations Uroš!!

• 9/1/2022

The BioSens8 team officially moved into the wonderful Nest.Bio Labs space in Cambridge, MA! They're excited to continue growing the team and commercialize their product alongside all the other impressive companies in that space.

• 7/28/2022

Our CEO, Uroš Kuzmanović, represented BioSens8 in the previous HealthTech Build panel discussing changing consumer trends, political climate, and standard of care in women's healthcare! Check out the recording if you missed it!

• 7/20/2022

BioSens8 was honored to participate in the third UMassM2D2 IMPACT Accelerator and partake in the Showcase Day at the UMass Lowell Innovation Hub! It's been an pleasure advancing and improving women's health alongside 9 other startups and our main sponsor Hologic, Inc.. BioSens8 won an Impact Program Award from RedCrow and a Judges Award from Upteaming!

• 6/27/2022

BioSens8 was selected as a semi-finalist in the 2022 Pepperdine Most Fundable Companies competition! We are part of a select group of approximately 100 semi-finalists chosen from over 4,000 participants nationwide.

• 6/10/2022

Our CEO, Uroš Kuzmanović, was nominated for the Tech Startup Hustle Project, a selective study investigating founder cognition supported by Ball State University and Indiana University! Congratulations!

• 5/18/2022

BioSens8 was awarded the Hatch@Nest.Bio award at the Nucleate New England Final Pitch Showcase!! This award provides us 6 months of lab space in the wonderful Nest.Bio incubator space in Cambridge, MA. We're excited to join the cohort there!

• 5/15/2022

BioSens8 represented TiE Boston at the TiE University Global Global Pitch Competition and won 1st place!! The TiE University Global pitch competition brought together 30 winning teams virtually from TIE Chapters in eight countries across three continents. Local TiE Charters had participation from 1,455 startup teams with 3,676 college students, representing 24 countries! Check out our press release here!

• 4/25/2022

BioSens8 was accepted into the M2D2 IMPACT Accelerator Program sponsored by Hologic, Inc. with a particular focus on innovating in women's healthcare! We're joined by 9 other startups on this 12 week program. Check out the previous cohort results and the current teams here.

• 4/6/2022

BioSens8 won the 1st place prize at the M2D2 $200K Challenge!! What a thrilling night at the UMass Club downtown shared with other innovators, entrepreneurs, and investors. Thank you to Hologic, Inc., Massachusetts Life Sciences Center, and MPR Associates, Inc. for sponsoring our efforts! Check out event recap here.

• 3/30/2022

BioSens8 won 1st place in the TiE Boston - University Regional Pitch Competition! We were among 90 teams from across the world who have made it to the global cohort after competing with 3660 student entrepreneurs from 1451 teams spanning 24 countries. We'll be participating in the global pitch competition as a result!

• 3/15/2022

BioSens8 progressed through the semi-final round and will participate in the 2022 MIT Sloan Healthcare Innovations Prize Finals! We're excited to pitch on 3/31/22!

• 3/9/2022

BioSens8 is once again a M2D2 $200K Challenge Finalist! Come watch us pitch in person on 3/22/22!

• 2/24/2022

BioSens8 advanced as a semi-finalists for the TiE Boston - University Regional Pitch Competition! We'll be pitching on 3/30/2022 for a chance to advance to the finals!

• 12/24/2021

BioSens8 was accepted into the Nucleate accelerator 2022 cohort! We'll be working through Spring engaging with clinical and business mentors to grow our company.

• 11/9/2021

BioSens8 is participating as a host company in Brown University's PRIME graduate program in order to discover potential markets we can enter with our IP.

• 10/12/2021

BioSens8 engaged in NSF's Beat the Odds Bootcamp in order to complete even further customer discovery in the human fertility market segment.

• 9/20/2021

BioSens8 is participating as a host company in the Boston University Questrom business school class, Bench to Bedside, to discover potential markets our platform technology can be applied toward and then follow with customer discovery!

• 9/14/2021

BioSens8 is participating as a host company in the MIT Sloan business school class, E-Lab, to diver deeper into unmet needs and identify the value propositions of our progesterone biosensor in the FemTech space!

• 7/20/2021

NSF has awarded our STTR Phase I proposal for developing a novel progesterone biosensor for monitoring fertility health! We're delighted to have the support of NSF, the funds will be used for achieving technical milestones required for commercialization.

• 6/28/2021

BioSens8 was selected from more than 3000 global applicants to join the MassChallenge 2021 cohort! We're excited to partake alongside 228 other startups!

• 5/3/2021

Boston University has awarded Dr. James Galagan with the Ignition Award! The funds will be used for R&D work toward bringing a novel animal healthcare biosensor to market.

• 4/7/2021

BioSens8 was awarded the 2nd place prize at the M2D2 $200K Challenge! We're thrilled to be supported by M2D2 with a cash award! Check out our award winning pitch.

• 4/7/2021

BioSens8 pitched in front of a panel of Med Tech judges including industry leaders, investors, and practitioners for the BU Ignition Award.

• 3/8/2021

BioSens8 was selected as a M2D2 $200K Finalist! We were one of 15 startups (out of more than 170 worldwide entrants) in the running for $200,000 in in-kind services and research support from sponsors that include UMass Lowell, Amgen, Boston Scientific, Johnson & Johnson Innovation, Massachusetts Life Sciences Center, Mintz, and others.

The virtual M2D2 $200K Challenge Finalist Pitch-off being hosted through Zoom on Wednesday, March 24^th. Register for free and watch us pitch here!

• 3/4/2021

BioSens8 successfully submitted a NSF STTR Phase I application.

• 2/11/2021

BioSens8 was selected as a Boston University Ignition Award finalist! Our full proposal was well received by the Ignition Review Committee, made up of outside representatives (investors, industry) and BU academics. As a finalist, BioSens8 will present for the Ignition Award on 4/7/2021.

• 12/16/2020

BioSens8 officially incorporated.

• 11/23/2020

BioSens8 was selected to submit a full proposal for the Boston University Ignition Award! The Ignition Award program is designed to help Boston University researchers bring their projects with commercial potential to the next level.

• 10/15/2020

BioSens8 was accepted to partake in the NSF NE I-Corps Spark Program to perform customer discovery!

Contact

If you wish to invest, become a business partner, license our technology or require a biosensor solution

please contact: uros@biosens8.com